Kenya Pushes for Pharmaceutical Manufacturing Hub as President Ruto Champions AIM2030 Agenda

Kenya Pushes for Pharmaceutical Manufacturing Hub as President Ruto Champions AIM2030 Agenda

H.E. Dr. William Samoei Ruto, President of the Republic of Kenya has reaffirmed Kenya’s commitment to becoming a regional pharmaceutical manufacturing and health innovation hub, as leaders and global partners convened in Nairobi for a high-level breakfast meeting held on the sidelines of the Africa Forward Summit 2026 under the Africa Initiative for Medical Access and Manufacturing (AIM2030).

The meeting brought together government officials, development partners, and private sector stakeholders to discuss Africa’s efforts to strengthen local manufacturing of medicines and vaccines, improve health security, and accelerate industrial transformation across the continent. Speaking during the meeting, President Ruto said Kenya is taking deliberate steps to strengthen its pharmaceutical ecosystem and enhance the country’s competitiveness in healthcare manufacturing. The President noted that Kenya’s broader objective is to position itself as a strategic regional hub for pharmaceutical manufacturing, health innovation, and medical supply chains serving both domestic and African markets.

President Ruto further attributed Kenya’s growing attractiveness to investors to its strategic location as the gateway to Eastern Africa’s rapidly expanding economic bloc, supported by strong logistics infrastructure, an expanding domestic market, and a dynamic investment environment.

The discussions at the AIM2030 breakfast meeting focused on Africa’s urgent need to reduce dependence on imported medicines and vaccines despite carrying a significant share of the global disease burden. Participants observed that the COVID-19 pandemic exposed major vulnerabilities in global supply chains and underscored the importance of strengthening local production capacity across the continent.

Leaders and partners described AIM2030 as a practical framework aimed at doubling Africa’s local manufacturing of essential health products, expanding equitable access to affordable and quality medicines, and strengthening regional health systems. The initiative also seeks to create skilled jobs, attract investment, and develop a more resilient and competitive pharmaceutical industry across Africa. Participants emphasized that achieving these goals will require coordinated implementation, including strengthening regulatory systems, harmonizing African markets, improving procurement and trade efficiency, investing in research and development, and mobilizing financing to scale up production and reduce investment risks.

The meeting called for stronger collaboration between governments, development partners, and the private sector to transform Africa’s pharmaceutical sector and advance the continent’s long-term health and economic resilience.